Alimera Sciences Inc (ALIM)
3.76
-0.03
(-0.79%)
USD |
NASDAQ |
May 07, 12:45
Alimera Sciences Shareholders Equity (Quarterly): 46.17M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 46.17M |
September 30, 2023 | 48.84M |
June 30, 2023 | 46.23M |
March 31, 2023 | -18.92M |
December 31, 2022 | -20.81M |
September 30, 2022 | -18.08M |
June 30, 2022 | -12.34M |
March 31, 2022 | -8.603M |
December 31, 2021 | -2.605M |
September 30, 2021 | 1.502M |
June 30, 2021 | 5.891M |
March 31, 2021 | -11.96M |
December 31, 2020 | -7.978M |
September 30, 2020 | -7.633M |
June 30, 2020 | -7.53M |
March 31, 2020 | -5.404M |
December 31, 2019 | -4.445M |
September 30, 2019 | -6.476M |
June 30, 2019 | -3.682M |
March 31, 2019 | 0.646M |
December 31, 2018 | 2.722M |
September 30, 2018 | 2.971M |
June 30, 2018 | 5.538M |
March 31, 2018 | 8.551M |
December 31, 2017 | 14.92M |
Date | Value |
---|---|
September 30, 2017 | 20.76M |
June 30, 2017 | 21.70M |
March 31, 2017 | 20.07M |
December 31, 2016 | 25.59M |
September 30, 2016 | 30.03M |
June 30, 2016 | 11.80M |
March 31, 2016 | 16.89M |
December 31, 2015 | 26.32M |
September 30, 2015 | 33.36M |
June 30, 2015 | 33.33M |
March 31, 2015 | 40.57M |
December 31, 2014 | 49.52M |
September 30, 2014 | 8.223M |
June 30, 2014 | 13.66M |
March 31, 2014 | 10.65M |
December 31, 2013 | -4.925M |
September 30, 2013 | 9.198M |
June 30, 2013 | 9.971M |
March 31, 2013 | 25.74M |
December 31, 2012 | 39.14M |
September 30, 2012 | 11.80M |
June 30, 2012 | 16.85M |
March 31, 2012 | 20.97M |
December 31, 2011 | 24.98M |
September 30, 2011 | 30.58M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-20.81M
Minimum
Dec 2022
48.84M
Maximum
Sep 2023
0.6411M
Average
-6.476M
Median
Sep 2019
Shareholders Equity (Quarterly) Benchmarks
Eli Lilly and Co | 12.81B |
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -11.38M |
iBio Inc | 9.197M |
Theriva Biologics Inc | 39.70M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 153.52M |
Total Liabilities (Quarterly) | 107.35M |
Debt to Equity Ratio | 1.397 |
Current Ratio | 2.392 |
Net Debt Paydown Yield | -1.83% |